Alexander combines insights from genetics and spatial transcriptomics to understand how aberrant differentiation of cortical cell types can cause disease symptoms in neurodevelopmental disorders.

Previously, he was a graduate scientist at AstraZeneca, where he contributed to various parts of the drug development process for type 2 diabetes.

My timeline


My publications

Loading publications...